Medicare Enrolled

Dr. Samina Reza, MD

Medical Oncology · Zephyrhills, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
38135 MARKET SQ, Zephyrhills, FL 33542
8137802642
In practice since 2006 (19 years)
NPI: 1457460479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reza

Dr. Samina Reza is a medical oncology in Zephyrhills, FL, with 19 years in practice. Based on federal Medicare data, Dr. Reza performed 148,516 Medicare services across 1,311 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reza received a total of $10,130 from 70 pharmaceutical and/or device companies across 534 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in FL$ $10,130 industry payments

Medicare Practice Summary

Medicare Utilization ↗
148,516
Medicare services
Top 17% in FL for medical oncology
1,311
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,817 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)131,070$0$2
Epoetin alfa injection (Procrit) for anemia11,140$6$29
Denosumab injection (Prolia/Xgeva)2,040$19$47
Office visit, established patient (30-39 min)1,532$91$273
Drug injection, under skin or into muscle687$11$41
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg344$1$13
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less336$48$176
Infusion into a vein for hydration, each additional hour278$10$33
Infusion, normal saline solution, 250 cc254$1$2
Irrigation of implanted venous access drug delivery device211$17$67
New patient office visit, complex (60-74 min)163$163$523
Collection of blood sample from implanted device92$19$60
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less88$21$77
Injection, diphenhydramine hcl, up to 50 mg79$1$3
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour77$16$53
Administration of chemotherapy into vein, 1 hour or less57$89$345
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle36$54$195
Office visit, established patient (20-29 min)21$40$186
Office visit, established patient, complex (40-54 min)11$127$366
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
88.9% high complexity
9.7% medium
1.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,130
Total received (2018-2024)
Avg $1,447/year across 7 years
Top 42% in FL for medical oncology
70
Companies
534
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,722 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$408 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$819
2023
$1,714
2022
$2,032
2021
$779
2020
$1,289
2019
$1,691
2018
$1,806

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,551
PFIZER INC.
$970
Lilly USA, LLC
$930
Eisai Inc.
$563
Janssen Biotech, Inc.
$488
AstraZeneca Pharmaceuticals LP
$347
Astellas Pharma US Inc
$337
Gilead Sciences, Inc.
$326
Merck Sharp & Dohme Corporation
$307
Incyte Corporation
$276
Amgen Inc.
$269
Genentech USA, Inc.
$250
EISAI INC.
$233
Bayer HealthCare Pharmaceuticals Inc.
$212
GENZYME CORPORATION
$194
Bayer Healthcare Pharmaceuticals Inc.
$192
Merck Sharp & Dohme LLC
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
Regeneron Healthcare Solutions, Inc.
$158
Kite Pharma, Inc.
$141
Pharmacyclics LLC, An AbbVie Company
$102
Daiichi Sankyo Inc.
$95
E.R. Squibb & Sons, L.L.C.
$94
Janssen Pharmaceuticals, Inc
$88
Celgene Corporation
$84
Myovant Sciences Inc.
$83
Alexion Pharmaceuticals, Inc.
$83
Rigel Pharmaceuticals, Inc.
$83
Seattle Genetics, Inc.
$64
Pharmacosmos Therapeutics Inc.
$62
EMD Serono, Inc.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$55
Global Blood Therapeutics, Inc.
$54
GlaxoSmithKline, LLC.
$53
INSYS Therapeutics Inc
$52
Sumitomo Pharma America, Inc.
$45
Dova Pharmaceuticals
$44
Taiho Oncology, Inc.
$43
Helsinn Therapeutics (U.S.), Inc.
$42
CSL Behring
$41
Sobi, Inc
$39
AVEO Pharmaceuticals, Inc.
$39
TESARO, Inc.
$35
Karyopharm Therapeutics Inc.
$34
GE HealthCare
$33
MEDIVATION FIELD SOLUTIONS LLC
$33
Ipsen Biopharmaceuticals, Inc
$30
ARRAY BIOPHARMA INC
$30
ABBVIE INC.
$28
Seagen Inc.
$28
Blueprint Medicines Corporation
$27
Mylan Institutional Inc.
$26
Stemline Therapeutics Inc.
$26
Alnylam Pharmaceuticals Inc.
$25
Aveo Pharmaceuticals, Inc.
$25
MorphoSys, US Inc.
$21
Dendreon Pharmaceuticals LLC
$21
Aurobindo Pharma USA, Inc.
$20
Telix Pharmaceuticals
$19
Lexicon Pharmaceuticals, Inc.
$19
CTI BioPharma Corp.
$18
JAZZ PHARMACEUTICALS INC.
$18
PORTOLA PHARMACEUTICALS, INC.
$17
Acrotech Biopharma Inc.
$17
Sysmex Inostics Inc
$16
Exelixis Inc.
$14
SOBI, INC
$14
PUMA BIOTECHNOLOGY, INC.
$13
Agios Pharmaceuticals, Inc.
$13
Advanced Accelerator Applications
$12
Top 3 companies account for 34.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BELEODAQ · BEVYXXA · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · EMEND · ENHERTU · ERBITUX · EVENITY · Enhertu · Erleada · FASLODEX · FOTIVDA · Fulphila · GAUCHER-DISEASE · GILOTRIF · GIVLAARI · Halaven · Hizentra · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · Jivi · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Marqibo · Monoferric · NERLYNX · NINLARO · NUCALA · Neulasta · Nexavar · Nplate · Nubeqa · OPDIVO · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RETEVMO · Revlimid · Rezlidhia · SANDOSTATIN · SANDOSTATIN LAR · SCEMBLIX · SHINGRIX · SOLIRIS · SUBSYS · SYNDROS · Soliris · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · Tavalisse · Trodelvy · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vitrakvi · Vonjo · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a medical oncology in Zephyrhills?
Compare medical oncologys in the Zephyrhills area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
41
Per 100K population
7.0
County median income
$67,384
Nearest hospital
Adventhealth Zephyrhills
2.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reza is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reza experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Reza performed 131,070 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reza receive payments from pharmaceutical companies?
Yes. Dr. Reza received a total of $10,130 from 70 companies across 534 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reza's costs compare to other medical oncologys in Zephyrhills?
Dr. Reza's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →